A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine.

Filippi, F; Baraldi, C; Zinzani, P L; Casadei, B; Pileri, A

Filippi, F; Baraldi, C; Zinzani, P L; Casadei, B; Pileri, A.

Filippi F; Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Baraldi C; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Zinzani PL; Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Casadei B; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Pileri A; IRCCS Azienda Ospedaliero, Istituto di Ematologia 'Seràgnoli', Università di Bologna, Bologna, Italy.

J Eur Acad Dermatol Venereol ; 36(10): e747-e749, 2022 10.

Article in English | MEDLINE | ID: covidwho-1986023

Subject(s)

COVID-19 Vaccines; COVID-19; Pityriasis Lichenoides; Aged; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Male

Keywords

COVID-19; drug rash; vaccine; viral disease

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pityriasis Lichenoides / COVID-19 Vaccines / COVID-19 Type of study: Case report / Observational study Topics: Vaccines Limits: Aged / Humans / Male Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2022 Document Type: Article Affiliation country: Jdv.18269

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google